Research Article

Expression of Ribonucleotide Reductase Subunit-2 and Thymidylate Synthase Correlates with Poor Prognosis in Patients with Resected Stages I–III Non-Small Cell Lung Cancer

Table 3

Patients characteristics, clinicopathologic features, and IHC analysis: association with OS. Results from Kaplan-Meier univariate and Cox multiple regression analyses.

Covariates5-year survivalKaplan-MeierCox regression
DeathsSP
%%HR95% CI valueHR95% CI value

Gender0.9670.611
 Female20945.054.611
 Male622845.254.21.120.51–2.471.280.50–3.30
Age at diagnosis0.8500.619
 ≤70 years462043.556.511
 >70 years361747.250.61.060.55–2.031.220.56–2.66
Smoking habit0.0660.091
 Ex/never-smoker28932.167.211
 Current smoker542851.947.71.990.94–4.241.980.90–4.39
Pathological TNM <0.001<0.001
 Stage I441227.371.911
 Stage II 15960.040.02.811.18–6.693.511.35–9.07
 Stage III231669.730.44.442.08–9.466.542.86–14.93
Histological type0.9980.857
 Nonsquamous542546.352.911
 Squamous281242.956.90.970.49–1.930.920.37–2.31
ERCC10.1260.059
 ≤140331226.461.411
 >140492551.047.51.700.85–3.392.080.97–4.44
BRCA10.3080.750
 Negative 361440.960.811
 Positive 452260.046.71.420.72–2.771.140.51–2.54
TS0.2420.023
 Negative662740.958.811
 Positive15960.040.01.560.74–3.322.931.16–7.42
p53R20.2970.699
 Negative572747.452.111
 Positive24937.561.90.670.32–1.430.700.27–1.83
TUBB3 (median -score)0.1520.354
 ≤60422252.446.811
 >60401537.562.30.620.32–1.190.680.30–1.55
RRM1 (median -score)0.8320.624
 ≤120431944.254.711
 >120381744.755.31.070.56–2.070.820.36–1.84
RRM2 (median -score)0.0690.031
 ≤140421635.761.911
 >140392153.845.91.840.95–3.562.261.08–4.74

SP = cumulative probability of surviving, expression level missing for 1 subject, log-rank (Mantel-Cox) test, test for trend, Cox regression analysis performed on 81 subjects with complete data: HR and 95% CI estimated from the final regression model for covariates retained in the model and from the full model for variables removed, and likelihood ratio test value.